Fundraising Fox

Sitryx

Founded 2018 Β· 49 employees on LinkedIn Β· 4 known investors

Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism. It has entered a global licensing and research collaboration with Eli Lilly and Company.

BiotechDeep TechHealthtech

Investors Β· 4

Longwood Fundβœ“ verifiedBoston
Oxford Science Enterprisesβœ“ verifiedOxford Β· $63.5K – $31.8M
Sofinnova Partnersβœ“ verifiedParis Β· $540K – $27M
SV Health Investorsβœ“ verifiedBoston Β· $1M – $20M

Frequently asked questions

What does Sitryx do?
Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism. It has entered a global licensing and research collaboration with Eli Lilly and Company.
Who are Sitryx's investors?
Sitryx's investors include Longwood Fund, Oxford Science Enterprises, Sofinnova Partners, SV Health Investors.